glp 1 for psoriasis The potential role of GLP-1 receptor agonists in the management of psoriatic disease: a scoping review GLP-1 Agonists and Psoriatic Disease

37, e257

When combined with a tailored low-calorie, low-fat diet and regular exercise, overweight adults including those with high blood pressure, diabetes, or high cholesterol can experience substantial improvements in various health indicators

How do doctors test intestinal permeability

NEJM Dec 2025) 12 None (no approved label) MTC thyroid C-cell (rodent, human relevance unestablished) 28 None published None published Once weekly, subcutaneous Once weekly, subcutaneous US: late 2027 earliest (NDA Q4 2026 at soonest) 22 Already approved (US: 2022/2023/2024

Results Training data We used experimental potency measurements (EC 50 ) at both GCGR and GLP-1R for a total of 125 peptide variants to fit models that relate peptide sequences to in vitro activity against each receptor

A.LoyttyniemiE.SalminenS.et al (2020)